1 / 8

Molecular Cytogenetics Market Research Report 2023

Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023.The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal abnormalities.

psmarket
Download Presentation

Molecular Cytogenetics Market Research Report 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Cytogenetics Market Size to Reach $3.3 Billion by 2023

  2. Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023. The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal abnormalities. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=molecular-cytogenetics-market

  3. Based on offering, the molecular cytogenetics market has been categorized into consumables, software and services and instruments. Globally, the market for software and services is expected to register fastest growth, with CAGR of 10.5% during the forecast period. This can be attributed to rapid adoption of automation in laboratory process and rising preference for outsourcing of expensive services. Based on technology, the molecular cytogenetics market has been categorized into comparative genomic hybridization (CGH), fluorescence in-situ hybridization (FISH), immunohistochemistry, karyotyping and others. The karyotyping technology market for molecular cytogenetics is further categorized into spectral and virtual. In 2017, spectral karyotyping held larger share, of 66.0%, in molecular cytogenetics market, owing to the usage of these technique for the detection of complex chromosomal aberration as well as for identification of new leukaemia subgroups.

  4. During the forecast period, the molecular cytogenetics market is expected to witness fastest growth in personalized medicine application, at a CAGR of 10.1%. This growth is attributable to rise in demand for precision medicine coupled with high investments in research and development. Browse report overview with detailed TOC on "Molecular Cytogenetics Market by Offering (Consumables, Software & Services, Instruments), by Technology (Comparative Genomic Hybridization [Array Based, Standard], Fluorescence In-Situ Hybridization, Immunohistochemistry, Karyotyping [Spectral, Virtual]), by Application (Cancer, Genetic Disorders, Personalized Medicine), by End User (Clinical & Research Laboratories, Academic Research Institutes, Hospitals & Pathology Laboratories, Pharmaceutical & Biotechnology Companies), by Geography (U.S., Canada, Germany, U.K., Japan, China, Brazil, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2023" at: https://www.psmarketresearch.com/market-analysis/molecular-cytogenetics-market

  5. Based on end user, the molecular cytogenetics market has been classified into clinical and research laboratories, academic research institutes, hospitals and pathology laboratories and pharmaceutical and biotechnology companies. Among these, clinical and research laboratories held the largest share as an end-user category during the historical period in this market and accounted for a 33.4 % share in 2017.

  6. Globally, key players in the molecular cytogenetics industry are developing new instruments and tests for the molecular diagnosing, genetic screening and other tests. For instance, in July 2017, Quest Diagnostics announced the launch of a genetic screening service, QHerit. The service is for the detection of genetic risk associated to offspring through passing of heritable disorders. The QHerit Pan-Ethnic Expanded Carrier Screen is a panel of tests for the 22 heritable diseases cited under new screening guidelines issued in March 2017 by the American College of Gynecology (ACOG). Some of the other key players operating in the molecular cytogenetics industry include Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann La-Roche AG, PerkinElmer Inc., IlluminaInc, Agilent Technologies Inc and NeoGenomics Inc.

  7. Download report sample at: https://www.psmarketresearch.com/market-analysis/molecular-cytogenetics-market/report-sample

  8. GET IN TOUCH THANK YOU! For information regarding permissions and other queries Kindly write to: US/Canada Toll-Free: 1-888-778-7886

More Related